Investor Relations rodneyhoganii September 10, 2024

Investor Relations

As a valued investor, this section serves as a comprehensive resource hub to provide you with up-to-date and relevant information about our company’s financial performance, strategic objectives, and overall investment proposition.

Overview

Retractable Technologies, Inc. designs, develops, manufactures and markets safety needle devices for the healthcare industry. The Company’s VanishPoint® products utilize a patented friction ring mechanism. VanishPoint and EasyPoint safety products are designed specifically to prevent needlestick injuries and to prevent reuse. Advantages of the Company’s products include protection from needlestick injuries, prevention of cross contamination through reuse, and reduction of disposal and other associated costs.

+ United States of America Employees
Patents (Other Patents Pending)
Products
  • VanishPoint Syringe
  • VanishPoint Insulin Syringe
  • EasyPoint Retractable Needle
  • EasyPoint Blood Collection Tube Holder with Needle
  • VanishPoint Blood Collection Set
  • VanishPoint IV Catheter


Thomas J. Shaw
Chairman, President, CEO

Michele M. Larios
Vice President and General Counsel

John W. Fort III
Vice President and CFO, Treasurer

Russell B. Kuhlman
Vice President, Sales Development

Kathryn M. Duesman
Vice President of Clinical Affairs

Lawrence G. Salerno
Director of Operations

R. John Maday
Production Manager

Jenny Margolis
Product Development Manager